|
Mir Imran founded InCube Labs, a multi-disciplinary research lab, in 1995 and DFJ InCube Ventures, a life sciences venture fund, in 2008 to focus on his passion: creating medical solutions that change the standard of care in critical healthcare markets. Mir began his career as a med-tech entrepreneur in the late 1970's and has founded numerous game-changing companies since those early days.
Over the decades, he has become one of the leading inventors and entrepreneurs in healthcare. Mir now holds more than 200 issued patents and is perhaps most well known for his pioneering contributions to the first FDA-approved Automatic Implantable Cardioverter Defibrillator, a device sold to Eli Lilly and is now part of Guidant. Additionally, Mir has invented a number of breakthrough devices that set new standards of care for their industries.
As an entrepreneur, Mir has founded more than 20 medical device companies; 15 of his companies have seen “liquidity events” (IPO/Acquisition) generating >57% IRR. Mir currently holds board seats with Bodymedia, Corhythm, eGeen, Entrack, Fe2, Intrapace, Modulus, Neurolink, NFocus, and Spinal Modulation.
Mir is currently Chairman and CEO of InCube Labs and Modulus Inc., a manufacturing and product development company focused on the medical device market. For more information on Mir and his companies, go to www.incubelabs.com and www.modulusinc.com.
|
